Blackstone Life Sciences announces $4.6bn fundraise

The $4.6 billion final close of Blackstone Life Sciences V was not only oversubscribed -- it was also the largest life sciences private fund to be raised to date, according to Blackstone officials.

The firm said it has already invested and committed nearly $1 billion from the fund over the past three months, including deals with Alnylam, Reata Pharmaceuticals and Continue Reading

Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Annual subscriptions get you the most bang for your buck, including access to Alternatives Watch Research articles and out Annual Investor Compendium.

Monthly subscriptions and discounted corporate plans for up to 100 members also available.

Related Articles

Back to top button

Start Your Days in the Know

 

Get fresh alts intel in your inbox with our FREE newsletter!

You have Successfully Subscribed!